Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Queensland Health
Harvard Business School
US Department of Justice
Cerilliant
McKesson
Cantor Fitzgerald
Baxter
Colorcon

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020044

« Back to Dashboard

NDA 020044 describes EXOSURF NEONATAL, which is a drug marketed by Glaxosmithkline and is included in one NDA. Additional details are available on the EXOSURF NEONATAL profile page.

The generic ingredient in EXOSURF NEONATAL is cetyl alcohol; colfosceril palmitate; tyloxapol. There are ninety-one drug master file entries for this compound. Additional details are available on the cetyl alcohol; colfosceril palmitate; tyloxapol profile page.
Summary for 020044
Tradename:EXOSURF NEONATAL
Applicant:Glaxosmithkline
Ingredient:cetyl alcohol; colfosceril palmitate; tyloxapol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FOR SUSPENSION;INTRATRACHEALStrength12MG/VIAL;108MG/VIAL;8MG/VIAL
Approval Date:Aug 2, 1990TE:RLD:No

Expired US Patents for NDA 020044

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Queensland Health
UBS
Federal Trade Commission
Farmers Insurance
Daiichi Sankyo
Chinese Patent Office
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.